Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Lactate dehydrogenase A pseudogene 2 (LDHAP2) is a non-protein-coding gene classified as a pseudogene. It shares high sequence similarity with the functional lactate dehydrogenase A gene but does not encode a functional enzyme due to disabling mutations. As a pseudogene, LDHAP2 is generally not expressed or translated and has no known biological, therapeutic, or pathological relevance[4]. LDHAP2 should not be confused with lactate dehydrogenase A (LDHA), which is an active enzyme target involved in metabolic pathways. LDHAP2's annotation as a "target" is incorrect for drug development and molecular biology applications.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Lactate dehydrogenase A pseudogene 2 (LDHAP2).